Global Breast Cancer Diagnostics Market Overview: Revenue, Size, Trend, Analysis and CAGR of 4.7% By End of 2022

A fresh study, covering “Breast Cancer Diagnostics Market Forecast, Trend Analysis & Competition Tracking: Global Review 2017 to 2022” has been broadcasted to wide online repository of Fact MR, which presents deep focus on the Healthcare Market. This smart study contains precise data that offers a clear insight about market current scenario and future projections for the benefit of readers. Moreover, the study enclosed significant data which tends to make the research a powerful source for analysts and industry experts who are looking to gain necessary knowledge about the prevailing market trends, opportunities and drivers present in the Breast Cancer Diagnostics Market.

Request For Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=55

Introduction of Hybrid Imaging Instruments Offering Enhanced Accuracy to Drive Growth of the Market

The global breast cancer diagnostics market has been witnessing a robust transformation on the back of several technological advancements in the diagnostic platforms. The market has witnessed the introduction of hybrid imaging instruments which offer an enhanced accuracy. These advancements have been augmenting growth of the global breast cancer diagnostics market. Increasing incidences of breast cancer and growth in older female population are expected to create lucrative growth opportunities for breast cancer diagnostics. In contrast, shortage of skilled and trained personnel is expected to pose a major challenge to the market growth of breast cancer diagnostics.

By test type, BRCA is expected to remain dominant in the market, with sales poised to surpass US$ 500 Mn by 2022-end. CA test for breast cancer are expected to exhibit the highest CAGR in the market through 2022, followed by ER & PR test. However, revenue from CA, and ER & PR tests will remain low during the forecast period. HER 2 test will remain the second largest test type segment in the global breast cancer diagnostics market. Revenue from EGFR mutation test will continue to be low in the global breast cancer diagnostics market.

Hospital-associated Labs to Remain the Largest End-Users in Breast Cancer Diagnostics Market

Hospital-associated labs are expected to remain the largest end-users of breast cancer diagnostics in the global market. Breast cancer diagnostics in hospital-associated labs will account for the largest revenues by 2022-end, followed by independent diagnostic laboratories. Cancer research institutes are expected to register the highest CAGR through 2022.

Competition Tracking

Key market players mentioned in Fact.MR’s report include Abbott Laboratories, Roche Holding AG, Thermo Fischer Scientific, Inc., Siemens AG, Bio-Rad Laboratories, Inc., Illumina, Inc., Biocept, Inc., Epigenomics AG, AstraZeneca plc, Myriad Genetics, Inc., and Quest Diagnostics Incorporated.

Browse Full Report With TOC- https://www.factmr.com/report/55/breast-cancer-diagnostics-market

Table of Content

Chapter 1 Global Breast Cancer Diagnostics Market - Executive Summary 19

Chapter 2 Global Breast Cancer Diagnostics Market Overview 21
2.1 Introduction 21
    2.1.1 Global Breast Cancer Diagnostics Market Taxonomy 21
    2.1.2 Global Breast Cancer Diagnostics Market Definition 21
2.2 Global Breast Cancer Diagnostics Market Size (US$ Mn) and Forecast, 2012-2022 22
    2.2.1 Global Breast Cancer Diagnostics Market Y-o-Y Growth 22
2.3 Global Breast Cancer Diagnostics Market Dynamics 22
    2.3.1 Drivers 22
    2.3.2 Restraints 22
    2.3.3 Trends 23
2.4 Supply Chain 23
2.5 Epidemiology 23
2.6 List of Distributors 23
2.7 Average Pricing Analysis 23
2.8 Regulations 24
2.9 Key Participants Market Presence (Intensity Map) By Region 24

Chapter 3 Global Breast Cancer Diagnostics Market Analysis and Forecast By Test Type 25
3.1 Global Breast Cancer Diagnostics Market Size and Forecast By Test Type, 2012-2022 25
    3.1.1 BRCA Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 25
          3.1.1.1 Revenue (US$ Mn) Comparison, By Region 25
          3.1.1.2 Market Share Comparison, By Region 26
          3.1.1.3 Y-o-Y growth Comparison, By Region 27
    3.1.2 ER & PR Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 28
          3.1.2.1 Revenue (US$ Mn) Comparison, By Region 28
          3.1.2.2 Market Share Comparison, By Region 29
          3.1.2.3 Y-o-Y growth Comparison, By Region 30
    3.1.3 CEA Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 31
          3.1.3.1 Revenue (US$ Mn) Comparison, By Region 31
          3.1.3.2 Market Share Comparison, By Region 32
          3.1.3.3 Y-o-Y growth Comparison, By Region 33

Continue…..

Request For Discount On This Report- https://www.factmr.com/connectus/sample?flag=D&rep_id=55

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com/
Web: https://www.factmr.com/

This release was published on openPR.